• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NUZ

NEURIZON THERAPEUTICS LIMITED - Announcements

13.6% ! 12.5¢
Market Cap $61.53M  !

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company... Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon's strategy is to accelerate access to effective ALS treatments for patients, while exploring NUZ-001’s potential for broader neurodegenerative applications.More

Corporate Spotlight

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease.
View the full Corporate Spotlight arrow Created with Sketch.

NUZ ANNOUNCES STRONG RESULTS IN LATEST STUDY

Announcements



NUZ Appointment of Chief Financial Officer22/04/25 download Created with Sketch. 363.89KB
NUZ Leadership team strengthened with strategic appointments17/04/25 download Created with Sketch. 197.75KB
NUZ NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 CellsPRICE SENSITIVE04/04/25 download Created with Sketch. 6.91MB
NUZ NUZ-001 Shows Positive Results in Human 3D Brain ModelPRICE SENSITIVE01/04/25 download Created with Sketch. 1.59MB
NUZ NUZ-001 shows promising respiratory outcomePRICE SENSITIVE24/03/25 download Created with Sketch. 720.88KB
NUZ Neurizon Commences Initiatives to Lift Clinical HoldPRICE SENSITIVE17/03/25 download Created with Sketch. 336.96KB
NUZ Appendix 4D - Half-year Financial Report - 31 December 2024PRICE SENSITIVE17/02/25 download Created with Sketch. 752.22KB
NUZ Neurizon to Present Latest Results and Key Updates17/02/25 download Created with Sketch. 6.55MB
NUZ FDA Guidance on NUZ-001 IND ApplicationPRICE SENSITIVE17/02/25 download Created with Sketch. 331.58KB
NUZ Notice of Company Update Webinar11/02/25 download Created with Sketch. 326.38KB
NUZ Change of Director's Interest Notices x307/02/25 download Created with Sketch. 654.31KB
NUZ US Patent granted for NUZ-001PRICE SENSITIVE05/02/25 download Created with Sketch. 364.85KB
NUZ Notification regarding unquoted securities - NUZ31/01/25 download Created with Sketch. 18.81KB
NUZ Appendix 4C & Quarterly UpdatePRICE SENSITIVE29/01/25 download Created with Sketch. 807.89KB
NUZ Neurizon updates on NUZ-001 IND ApplicationPRICE SENSITIVE17/01/25 download Created with Sketch. 291.01KB
NUZ Change of Share Registry16/01/25 download Created with Sketch. 309.18KB
NUZ Section 708A Cleansing Statement27/12/24 download Created with Sketch. 288.43KB
NUZ Application for quotation of securities - NUZ27/12/24 download Created with Sketch. 15.62KB
NUZ Neurizon Files IND Application to Support HEALEY ALS TrialPRICE SENSITIVE18/12/24 download Created with Sketch. 358.46KB
NUZ Neurizon Granted OMPD for NUZ-001 in EuropePRICE SENSITIVE17/12/24 download Created with Sketch. 328.67KB
NUZ Positive 8-month Interim Data from OLE StudyPRICE SENSITIVE16/12/24 download Created with Sketch. 787.5KB
NUZ Neurizon Presents Company Update and 2025 Outlook12/12/24 download Created with Sketch. 1.95MB
NUZ Neurizon Receives Additional R&D Tax Incentive RebatePRICE SENSITIVE11/12/24 download Created with Sketch. 340.81KB
NUZ Notice of Company Update Webinar05/12/24 download Created with Sketch. 325.23KB
NUZ Section 708A Cleansing Statement29/11/24 download Created with Sketch. 286.88KB
NUZ Application for quotation of securities - NUZ29/11/24 download Created with Sketch. 15.62KB
NUZ Updated Securities Trading Policy19/11/24 download Created with Sketch. 564.32KB
NUZ Correction to text positioning error in announcement15/11/24 download Created with Sketch. 977.1KB
NUZ Neurizon Presents Positive Preclinical Data on NUZ-001PRICE SENSITIVE15/11/24 download Created with Sketch. 4.26MB
NUZ NUZ-001 Reduces Aggregation of Key ALS Disease TargetPRICE SENSITIVE15/11/24 download Created with Sketch. 679.45KB
NUZ Positive opinion received on OMPD for NUZ-001 in EuropePRICE SENSITIVE11/11/24 download Created with Sketch. 327.54KB
NUZ Change of Director's Interest Notices x408/11/24 download Created with Sketch. 748.49KB
NUZ Notification regarding unquoted securities - NUZ07/11/24 download Created with Sketch. 20.35KB
NUZ Notification regarding unquoted securities - NUZ07/11/24 download Created with Sketch. 21.63KB
NUZ Notification regarding unquoted securities - NUZ07/11/24 download Created with Sketch. 17.62KB
NUZ Section 708A Cleansing Statement01/11/24 download Created with Sketch. 223.68KB
NUZ Application for quotation of securities - NUZ01/11/24 download Created with Sketch. 16.42KB
NUZ Application for quotation of securities - NUZ01/11/24 download Created with Sketch. 15.56KB
NUZ Application for quotation of securities - NUZ01/11/24 download Created with Sketch. 16.14KB
NUZ Application for quotation of securities - NUZ01/11/24 download Created with Sketch. 15.76KB
NUZ Appendix 4C & Quarterly UpdatePRICE SENSITIVE31/10/24 download Created with Sketch. 659.44KB
NUZ Neurizon Presents Phase 1 MEND Study Data at NEALS Meeting25/10/24 download Created with Sketch. 1.31MB
NUZ PharmAust changes name to Neurizon Therapeutics15/10/24 download Created with Sketch. 331.63KB
NUZ Results of Annual General Meeting09/10/24 download Created with Sketch. 626.89KB
NUZ AGM Presentation09/10/24 download Created with Sketch. 2.64MB
NUZ Chairman's AGM Address09/10/24 download Created with Sketch. 578.17KB
NUZ PharmAust Receives R&D Tax Incentive RebatePRICE SENSITIVE09/10/24 download Created with Sketch. 534.48KB
NUZ Section 708A Cleansing Statement30/09/24 download Created with Sketch. 568.65KB
NUZ Application for quotation of securities - PAA30/09/24 download Created with Sketch. 15.53KB
NUZ EMA pre-submission meeting paves the way for OMPD Request17/09/24 download Created with Sketch. 275.88KB
NUZ Proposed issue of securities - PAA05/09/24 download Created with Sketch. 19.79KB
NUZ Notice of Annual General Meeting/Proxy Form05/09/24 download Created with Sketch. 1.78MB
NUZ Section 708A Cleansing Statement02/09/24 download Created with Sketch. 568.38KB
NUZ Application for quotation of securities - PAA02/09/24 download Created with Sketch. 15.53KB
NUZ Change of AGM Date02/09/24 download Created with Sketch. 534.63KB
NUZ Appendix 4G and Corporate Governance Statement30/08/24 download Created with Sketch. 838.9KB
NUZ Appendix 4E and 2024 Annual ReportPRICE SENSITIVE30/08/24 download Created with Sketch. 1.3MB
NUZ Positive Interim Study Results from OLE Study in ALSPRICE SENSITIVE26/08/24 download Created with Sketch. 1.04MB
NUZ AGM Date & Director Nominations Closing Date for AGM05/08/24 download Created with Sketch. 510.39KB
NUZ Section 708A Cleansing Statement30/07/24 download Created with Sketch. 568.78KB
NUZ Application for quotation of securities - PAA30/07/24 download Created with Sketch. 15.52KB
NUZ Appendix 4C & Quarterly UpdatePRICE SENSITIVE29/07/24 download Created with Sketch. 858.38KB
NUZ Change of Director's Interest Notices x229/07/24 download Created with Sketch. 591.17KB
NUZ Application for quotation of securities - PAA25/07/24 download Created with Sketch. 15.67KB
NUZ PharmAust Completes Share Purchase PlanPRICE SENSITIVE24/07/24 download Created with Sketch. 552.57KB
NUZ Investor Update - HEALEY ALS Platform Trial Selection15/07/24 download Created with Sketch. 3.33MB
NUZ Monepantel Selected for Entry into HEALEY ALS Platform TrialPRICE SENSITIVE15/07/24 download Created with Sketch. 555.88KB
NUZ Investor Briefings & Webinar Notice08/07/24 download Created with Sketch. 210.33KB
NUZ PharmAust Granted SME Status by European Medicines Agency01/07/24 download Created with Sketch. 570.9KB
NUZ Section 708A Cleansing Statement28/06/24 download Created with Sketch. 571.1KB
NUZ Notification regarding unquoted securities - PAA28/06/24 download Created with Sketch. 17.8KB
NUZ Application for quotation of securities - PAA28/06/24 download Created with Sketch. 16.48KB
NUZ Application for quotation of securities - PAA28/06/24 download Created with Sketch. 16.13KB
NUZ Share Purchase Plan Offer BookletPRICE SENSITIVE28/06/24 download Created with Sketch. 1.12MB
NUZ Share Purchase Plan Cleansing Notice28/06/24 download Created with Sketch. 533.97KB
NUZ Application for quotation of securities - PAA27/06/24 download Created with Sketch. 14.4KB
NUZ PharmAust Presentation21/06/24 download Created with Sketch. 3.9MB
NUZ Proposed issue of securities - PAA21/06/24 download Created with Sketch. 28.27KB
NUZ PharmAust raises $10 million via Placement and announces SPPPRICE SENSITIVE21/06/24 download Created with Sketch. 628.74KB
NUZ Initial Director's Interest Notice - K.MacFarlane19/06/24 download Created with Sketch. 279.29KB
NUZ Trading HaltPRICE SENSITIVE19/06/24 download Created with Sketch. 949.58KB
NUZ PharmAust's Phase 1 Study Data Presented at Major Conference18/06/24 download Created with Sketch. 555.53KB
NUZ Appointment of Non-Executive Director17/06/24 download Created with Sketch. 228.29KB
NUZ OLE Study update reveals impressive Survival DataPRICE SENSITIVE05/06/24 download Created with Sketch. 1019.13KB
NUZ Initial Director's Interest Notice - M.Thurn04/06/24 download Created with Sketch. 344.22KB
NUZ Final Director's Interest Notice - J.Clark04/06/24 download Created with Sketch. 328.16KB
NUZ Executive team strengthened, appointment of MD/CEO & new CSOPRICE SENSITIVE31/05/24 download Created with Sketch. 563.64KB
NUZ Change of Registered Office and Principal Place of Business28/05/24 download Created with Sketch. 292.65KB
NUZ Appointment of Company Secretary24/05/24 download Created with Sketch. 231.42KB
NUZ Investor Webinar Presentation17/05/24 download Created with Sketch. 2.38MB
NUZ PharmAust receives Orphan Drug Designation for monepantelPRICE SENSITIVE17/05/24 download Created with Sketch. 209.61KB
NUZ Initial Director's Interest Notice17/05/24 download Created with Sketch. 131.95KB
NUZ Final Director's Interest Notice17/05/24 download Created with Sketch. 244.88KB
NUZ PharmAust appoints Sergio Duchini as Non-Executive Chairman17/05/24 download Created with Sketch. 212.77KB
NUZ Final Director's Interest Notice14/05/24 download Created with Sketch. 226.24KB
NUZ Investor update14/05/24 download Created with Sketch. 217.69KB
NUZ Final Director's Interest Notice X 310/05/24 download Created with Sketch. 262.17KB
NUZ Initial Director's Interest Notice x 210/05/24 download Created with Sketch. 153.32KB
NUZ Cleansing Notice09/05/24 download Created with Sketch. 154.88KB
NUZ Application for quotation of securities - PAA09/05/24 download Created with Sketch. 15.48KB
NUZ Appointment of Chief Financial Officer
22/04/25 download Created with Sketch. 363.89KB
NUZ Leadership team strengthened with strategic appointments
17/04/25 download Created with Sketch. 197.75KB
NUZ NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 Cells
04/04/25PRICE SENSITIVE download Created with Sketch. 6.91MB
NUZ NUZ-001 Shows Positive Results in Human 3D Brain Model
01/04/25PRICE SENSITIVE download Created with Sketch. 1.59MB
NUZ NUZ-001 shows promising respiratory outcome
24/03/25PRICE SENSITIVE download Created with Sketch. 720.88KB
NUZ Neurizon Commences Initiatives to Lift Clinical Hold
17/03/25PRICE SENSITIVE download Created with Sketch. 336.96KB
NUZ Appendix 4D - Half-year Financial Report - 31 December 2024
17/02/25PRICE SENSITIVE download Created with Sketch. 752.22KB
NUZ Neurizon to Present Latest Results and Key Updates
17/02/25 download Created with Sketch. 6.55MB
NUZ FDA Guidance on NUZ-001 IND Application
17/02/25PRICE SENSITIVE download Created with Sketch. 331.58KB
NUZ Notice of Company Update Webinar
11/02/25 download Created with Sketch. 326.38KB
NUZ Change of Director's Interest Notices x3
07/02/25 download Created with Sketch. 654.31KB
NUZ US Patent granted for NUZ-001
05/02/25PRICE SENSITIVE download Created with Sketch. 364.85KB
NUZ Notification regarding unquoted securities - NUZ
31/01/25 download Created with Sketch. 18.81KB
NUZ Appendix 4C & Quarterly Update
29/01/25PRICE SENSITIVE download Created with Sketch. 807.89KB
NUZ Neurizon updates on NUZ-001 IND Application
17/01/25PRICE SENSITIVE download Created with Sketch. 291.01KB
NUZ Change of Share Registry
16/01/25 download Created with Sketch. 309.18KB
NUZ Section 708A Cleansing Statement
27/12/24 download Created with Sketch. 288.43KB
NUZ Application for quotation of securities - NUZ
27/12/24 download Created with Sketch. 15.62KB
NUZ Neurizon Files IND Application to Support HEALEY ALS Trial
18/12/24PRICE SENSITIVE download Created with Sketch. 358.46KB
NUZ Neurizon Granted OMPD for NUZ-001 in Europe
17/12/24PRICE SENSITIVE download Created with Sketch. 328.67KB
NUZ Positive 8-month Interim Data from OLE Study
16/12/24PRICE SENSITIVE download Created with Sketch. 787.5KB
NUZ Neurizon Presents Company Update and 2025 Outlook
12/12/24 download Created with Sketch. 1.95MB
NUZ Neurizon Receives Additional R&D Tax Incentive Rebate
11/12/24PRICE SENSITIVE download Created with Sketch. 340.81KB
NUZ Notice of Company Update Webinar
05/12/24 download Created with Sketch. 325.23KB
NUZ Section 708A Cleansing Statement
29/11/24 download Created with Sketch. 286.88KB
NUZ Application for quotation of securities - NUZ
29/11/24 download Created with Sketch. 15.62KB
NUZ Updated Securities Trading Policy
19/11/24 download Created with Sketch. 564.32KB
NUZ Correction to text positioning error in announcement
15/11/24 download Created with Sketch. 977.1KB
NUZ Neurizon Presents Positive Preclinical Data on NUZ-001
15/11/24PRICE SENSITIVE download Created with Sketch. 4.26MB
NUZ NUZ-001 Reduces Aggregation of Key ALS Disease Target
15/11/24PRICE SENSITIVE download Created with Sketch. 679.45KB
NUZ Positive opinion received on OMPD for NUZ-001 in Europe
11/11/24PRICE SENSITIVE download Created with Sketch. 327.54KB
NUZ Change of Director's Interest Notices x4
08/11/24 download Created with Sketch. 748.49KB
NUZ Notification regarding unquoted securities - NUZ
07/11/24 download Created with Sketch. 20.35KB
NUZ Notification regarding unquoted securities - NUZ
07/11/24 download Created with Sketch. 21.63KB
NUZ Notification regarding unquoted securities - NUZ
07/11/24 download Created with Sketch. 17.62KB
NUZ Section 708A Cleansing Statement
01/11/24 download Created with Sketch. 223.68KB
NUZ Application for quotation of securities - NUZ
01/11/24 download Created with Sketch. 16.42KB
NUZ Application for quotation of securities - NUZ
01/11/24 download Created with Sketch. 15.56KB
NUZ Application for quotation of securities - NUZ
01/11/24 download Created with Sketch. 16.14KB
NUZ Application for quotation of securities - NUZ
01/11/24 download Created with Sketch. 15.76KB
NUZ Appendix 4C & Quarterly Update
31/10/24PRICE SENSITIVE download Created with Sketch. 659.44KB
NUZ Neurizon Presents Phase 1 MEND Study Data at NEALS Meeting
25/10/24 download Created with Sketch. 1.31MB
NUZ PharmAust changes name to Neurizon Therapeutics
15/10/24 download Created with Sketch. 331.63KB
NUZ Results of Annual General Meeting
09/10/24 download Created with Sketch. 626.89KB
NUZ AGM Presentation
09/10/24 download Created with Sketch. 2.64MB
NUZ Chairman's AGM Address
09/10/24 download Created with Sketch. 578.17KB
NUZ PharmAust Receives R&D Tax Incentive Rebate
09/10/24PRICE SENSITIVE download Created with Sketch. 534.48KB
NUZ Section 708A Cleansing Statement
30/09/24 download Created with Sketch. 568.65KB
NUZ Application for quotation of securities - PAA
30/09/24 download Created with Sketch. 15.53KB
NUZ EMA pre-submission meeting paves the way for OMPD Request
17/09/24 download Created with Sketch. 275.88KB
NUZ Proposed issue of securities - PAA
05/09/24 download Created with Sketch. 19.79KB
NUZ Notice of Annual General Meeting/Proxy Form
05/09/24 download Created with Sketch. 1.78MB
NUZ Section 708A Cleansing Statement
02/09/24 download Created with Sketch. 568.38KB
NUZ Application for quotation of securities - PAA
02/09/24 download Created with Sketch. 15.53KB
NUZ Change of AGM Date
02/09/24 download Created with Sketch. 534.63KB
NUZ Appendix 4G and Corporate Governance Statement
30/08/24 download Created with Sketch. 838.9KB
NUZ Appendix 4E and 2024 Annual Report
30/08/24PRICE SENSITIVE download Created with Sketch. 1.3MB
NUZ Positive Interim Study Results from OLE Study in ALS
26/08/24PRICE SENSITIVE download Created with Sketch. 1.04MB
NUZ AGM Date & Director Nominations Closing Date for AGM
05/08/24 download Created with Sketch. 510.39KB
NUZ Section 708A Cleansing Statement
30/07/24 download Created with Sketch. 568.78KB
NUZ Application for quotation of securities - PAA
30/07/24 download Created with Sketch. 15.52KB
NUZ Appendix 4C & Quarterly Update
29/07/24PRICE SENSITIVE download Created with Sketch. 858.38KB
NUZ Change of Director's Interest Notices x2
29/07/24 download Created with Sketch. 591.17KB
NUZ Application for quotation of securities - PAA
25/07/24 download Created with Sketch. 15.67KB
NUZ PharmAust Completes Share Purchase Plan
24/07/24PRICE SENSITIVE download Created with Sketch. 552.57KB
NUZ Investor Update - HEALEY ALS Platform Trial Selection
15/07/24 download Created with Sketch. 3.33MB
NUZ Monepantel Selected for Entry into HEALEY ALS Platform Trial
15/07/24PRICE SENSITIVE download Created with Sketch. 555.88KB
NUZ Investor Briefings & Webinar Notice
08/07/24 download Created with Sketch. 210.33KB
NUZ PharmAust Granted SME Status by European Medicines Agency
01/07/24 download Created with Sketch. 570.9KB
NUZ Section 708A Cleansing Statement
28/06/24 download Created with Sketch. 571.1KB
NUZ Notification regarding unquoted securities - PAA
28/06/24 download Created with Sketch. 17.8KB
NUZ Application for quotation of securities - PAA
28/06/24 download Created with Sketch. 16.48KB
NUZ Application for quotation of securities - PAA
28/06/24 download Created with Sketch. 16.13KB
NUZ Share Purchase Plan Offer Booklet
28/06/24PRICE SENSITIVE download Created with Sketch. 1.12MB
NUZ Share Purchase Plan Cleansing Notice
28/06/24 download Created with Sketch. 533.97KB
NUZ Application for quotation of securities - PAA
27/06/24 download Created with Sketch. 14.4KB
NUZ PharmAust Presentation
21/06/24 download Created with Sketch. 3.9MB
NUZ Proposed issue of securities - PAA
21/06/24 download Created with Sketch. 28.27KB
NUZ PharmAust raises $10 million via Placement and announces SPP
21/06/24PRICE SENSITIVE download Created with Sketch. 628.74KB
NUZ Initial Director's Interest Notice - K.MacFarlane
19/06/24 download Created with Sketch. 279.29KB
NUZ Trading Halt
19/06/24PRICE SENSITIVE download Created with Sketch. 949.58KB
NUZ PharmAust's Phase 1 Study Data Presented at Major Conference
18/06/24 download Created with Sketch. 555.53KB
NUZ Appointment of Non-Executive Director
17/06/24 download Created with Sketch. 228.29KB
NUZ OLE Study update reveals impressive Survival Data
05/06/24PRICE SENSITIVE download Created with Sketch. 1019.13KB
NUZ Initial Director's Interest Notice - M.Thurn
04/06/24 download Created with Sketch. 344.22KB
NUZ Final Director's Interest Notice - J.Clark
04/06/24 download Created with Sketch. 328.16KB
NUZ Executive team strengthened, appointment of MD/CEO & new CSO
31/05/24PRICE SENSITIVE download Created with Sketch. 563.64KB
NUZ Change of Registered Office and Principal Place of Business
28/05/24 download Created with Sketch. 292.65KB
NUZ Appointment of Company Secretary
24/05/24 download Created with Sketch. 231.42KB
NUZ Investor Webinar Presentation
17/05/24 download Created with Sketch. 2.38MB
NUZ PharmAust receives Orphan Drug Designation for monepantel
17/05/24PRICE SENSITIVE download Created with Sketch. 209.61KB
NUZ Initial Director's Interest Notice
17/05/24 download Created with Sketch. 131.95KB
NUZ Final Director's Interest Notice
17/05/24 download Created with Sketch. 244.88KB
NUZ PharmAust appoints Sergio Duchini as Non-Executive Chairman
17/05/24 download Created with Sketch. 212.77KB
NUZ Final Director's Interest Notice
14/05/24 download Created with Sketch. 226.24KB
NUZ Investor update
14/05/24 download Created with Sketch. 217.69KB
NUZ Final Director's Interest Notice X 3
10/05/24 download Created with Sketch. 262.17KB
NUZ Initial Director's Interest Notice x 2
10/05/24 download Created with Sketch. 153.32KB
NUZ Cleansing Notice
09/05/24 download Created with Sketch. 154.88KB
NUZ Application for quotation of securities - PAA
09/05/24 download Created with Sketch. 15.48KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
12.5¢
Change
0.015(13.6%)
Mkt cap ! $61.53M
Open High Low Value Volume
12.0¢ 13.0¢ 12.0¢ $45.40K 368.6K

Buyers (Bids)

No. Vol. Price($)
1 457783 12.5¢
 

Sellers (Offers)

Price($) Vol. No.
13.0¢ 266325 5
View Market Depth
Last trade - 16.10pm 23/04/2025 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.